10大生物重磅药

Top 10 Blockbuster Biotech Drugs

Enbrel
Companies: Amgen, Wyeth, Takeda   安进，惠氏，武田
Sales: $7.66 billion in 2008 76.6亿美元
Indications: Rheumatoid Arthritis, Juvenile Idiopathic Arthritisc, Ankylosing Spondylitis, Plaque Psoriasis

Remicade (Infliximab)
Companies: J&J, Schering Plough, Mitsubishi Tanabe  先灵葆雅，三菱，田边
Sales: $6.2 billion in 2008  62亿美元
Indications: Plaque Psoriasi, Rheumatoid Arthritis, Psoriatic Arthritis, Adult Crohn's Disease, Pediatric Crohn's Disease,

Ulcerative Colitis, Ankylosing Spondylitis

Rituxan (Rituximab)
Company: Roche  罗氏
Sales: $5.5B in 2008
Indications: Non-Hodgkin's Lymphoma and Rheumatoid arthritis

Avastin (Bevacizumab)
Company: Roche  罗氏
Sales: $3.8 billion in 2008  38亿美元
Indications: Metastatic colorectal cancer, Non-squamous non-small cell lung cancer, Metastatic breast cancer,

Glioblastoma, Metastatic renal cell carcinoma

Herceptin (Trastuzumab)
Company: Roche 罗氏
Sales: $4.7B in 2008  47.8亿美元
Indications: Breast Cancer

Humira (Adalimumab)
Company: Abbott  雅培
Sales: $4.5 billion in 2008  45亿美元
Indications: Rheumatoid Arthritis, ployarticular juvenile idiopathic arthritis, psoriatic arthritis, Chronic plaque

psoriasis, Ankylosing Spondylitis, Chrone's disease

Lovenox (Enoxaparin)
Company: Sanofi Aventis 赛诺菲-安万特
Sales: $4 billion in 40亿美元
Indications: DVT Blood Clots

Lantus (Insulin)
Company: Sanofi Aventis  赛诺菲-安万特
Sales: $3.6 billion in 2008  36亿美元
Indications: Diabetes

Aranesp (Darbepoetin)
Company: Amgen  安进
Sales: $3.1 in 2008  31亿美元
Indications: Anemia

Gardasil
Company: Merck 默克
Sales: $2.8 billion in 2008   28亿美元
Indications: HPV and Cervical cancer prevention

注：

年销售额均超过20亿美元，26亿至76.6亿美元，
十大产品中，罗氏三个，安进二个，赛诺菲二个，强生一个，默克一个，雅培一个
罗氏的Avastin未来将成为销售额最高的重磅药之冠

转载编译自Fiercebiotech